Table 1. Demographic and clinical characteristics of study groups.
| Characteristics | Schizophrenia patients | Healthy controls | t | P |
|---|---|---|---|---|
| Number of subjects | 95 | 93 | - | |
| Age (years) | 33.6 ±7.8 | 33.0±10.2 | 0.482 | 0.633 |
| Gender (female/male), n | 41/54 | 48/45 | 1.654 | 0.246 |
| Antipsychotic dosage (mg/d), chlorpromazine equivalents | 446.54±341.60 | - | - | |
| Duration of illness (months) | 121.42±92.80 | - | ||
| PANSS Positive score Negative score General psychopathology Score Total score |
17.10±7.92 20.30±9.13 34.14±10.83 71.5±23.20 |
- - - - - |
- |
PANSS, Positive and Negative Syndrome Scale. Data are shown as the means ± standard deviation.